Holen Sie sich die Stockscreener-App
420.87
3.12%
-13.55
Vorhandelsmarkt:
420.87
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$434.42
Offen:
$434.44
24-Stunden-Volumen:
256.98K
Relative Volume:
1.04
Marktkapitalisierung:
$5.59B
Einnahmen:
$2.54B
Nettoeinkommen (Verlust:
$259.78M
KGV:
22.94
EPS:
18.3497
Netto-Cashflow:
$377.12M
1W Leistung:
-2.65%
1M Leistung:
-0.13%
6M Leistung:
-1.93%
1J Leistung:
-23.32%
1-Tages-Spanne:
$419.31
$434.99
1-Wochen-Bereich:
$419.31
$450.00
52-Wochen-Spanne:
$365.20
$562.76
Chemed Corp Stock (CHE) Company Profile
Firmenname
Chemed Corp
Sektor
Branche
Telefon
(513)762-6690
Adresse
SUITE 2600, CINCINNATI, OH
Compare CHE vs HCA, THC, DVA, FMS, EHC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CHE
Chemed Corp
|
420.87 | 5.59B | 2.54B | 259.78M | 377.12M | 18.35 |
HCA
Hca Healthcare Inc
|
378.51 | 83.97B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
173.17 | 14.92B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
203.83 | 13.08B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
22.37 | 12.02B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
102.38 | 10.16B | 6.07B | 793.80M | 464.40M | 5.9914 |
Chemed Corp Stock (CHE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-27 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-01-22 | Herabstufung | Jefferies | Buy → Hold |
| 2025-09-02 | Hochstufung | Jefferies | Hold → Buy |
| 2025-07-25 | Eingeleitet | Jefferies | Hold |
| 2020-03-11 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2019-11-01 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-09-06 | Bestätigt | BofA/Merrill | Buy |
| 2018-10-12 | Eingeleitet | BofA/Merrill | Buy |
| 2017-08-28 | Eingeleitet | KeyBanc Capital Mkts | Sector Weight |
| 2016-11-01 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2016-07-27 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2016-05-02 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2015-10-26 | Bestätigt | Oppenheimer | Outperform |
| 2015-10-26 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2015-09-22 | Bestätigt | Oppenheimer | Outperform |
| 2015-07-27 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2015-02-19 | Bestätigt | Oppenheimer | Outperform |
| 2014-09-23 | Bestätigt | Oppenheimer | Outperform |
| 2014-06-10 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2014-05-01 | Bestätigt | Oppenheimer | Outperform |
| 2013-09-10 | Bestätigt | Deutsche Bank | Hold |
| 2011-03-04 | Bestätigt | Barclays Capital | Underweight |
| 2011-02-17 | Bestätigt | Oppenheimer | Outperform |
| 2011-02-17 | Bestätigt | RBC Capital Mkts | Sector Perform |
Alle ansehen
Chemed Corp Aktie (CHE) Neueste Nachrichten
Director Andrea Lindell Sells 1,347 Shares of Chemed Corp (CHE) - GuruFocus
Chemed Corp director Andrea R. Lindell sells $602,553 in stock. By Investing.com - Investing.com South Africa
Chemed Corp director Andrea R. Lindell sells $602,553 in stock. - Investing.com
[Form 4] CHEMED CORP Insider Trading Activity - Stock Titan
Roto-Rooter Services Company Acquires South Texas Franchise for $12 Million - Quiver Quantitative
Roto-Rooter Buys Franchise Territory in Corpus Christi, Rio Grande Valley, and Beaumont, Texas - GlobeNewswire
Chemed Corp (CHE) Stock Analysis: A Robust Healthcare Play With Solid Financial Metrics - DirectorsTalk Interviews
ETFs Investing in Chemed Corporation Stocks - TradingView
TD Asset Management Inc Has $138.86 Million Stock Holdings in Chemed Corporation $CHE - MarketBeat
CHE News | CHEMED CORP (NYSE:CHE) - ChartMill
Activist Barington targets healthcare firm Chemed - MSN
Activist Barington Targets Healthcare Firm Chemed - Bloomberg.com
CHE Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
How (CHE) Movements Inform Risk Allocation Models - Stock Traders Daily
Chemed Corp (CHE) Stock Analysis: Evaluating a Healthcare Giant with a Potential 4.71% Upside - DirectorsTalk Interviews
CHE Technical Analysis & Stock Price Forecast - Intellectia AI
Chemed director Walsh sells $218,915 in stock By Investing.com - Investing.com Canada
Chemed Corp (CHE) Shares Fall 3.1% -- What GF Score of 78 Tells Investors - GuruFocus
Chemed director Walsh sells $218,915 in stock - Investing.com
Chemed (NYSE: CHE) director sells 500 shares in open-market trade - Stock Titan
CHE Q1 2026 Earnings: EPS Beats Estimates by 5.5%Pre-Earnings Drift - thelegaladvocate.com
Chemed Corp (CHE) Edges Higher Amid Steady Trading: Key Levels to WatchMA Crossover - The Legal Advocate
Chemed Corp (CHE) Q1 2026 Earnings: EPS Beats Expectations Amid Strong Operational PerformanceRevenue Surprise History - The Legal Advocate
Chemed Corp (CHE) Holds Steady Near Support Amid Narrow Trading RangeSupply Zone - The Legal Advocate
Chemed Corp (CHE) Stock Report: Navigating Valuation with a 25.60% ROE and a Modest Upside - DirectorsTalk Interviews
Trading Systems Reacting to (CHE) Volatility - Stock Traders Daily
Chemed Corporation 8-K SEC Filing Summary for May 18, 2026 – Key Entity Information and Voting Results - Minichart
Chemed stockholders elect board, ratify auditor, reject executive pay plan - Investing.com
Shareholders at Chemed (NYSE: CHE) vote down pay plan but back board - Stock Titan
Chemed (NYSE: CHE) director awarded 386 shares of company stock - Stock Titan
Chemed (NYSE: CHE) director granted 386 capital shares in stock award - Stock Titan
CHEMED CORP (CHE) director receives 386-share equity award at $440.77 value - Stock Titan
Chemed (NYSE: CHE) director receives stock award, boosting holdings to 5,925 shares - Stock Titan
Director at Chemed (NYSE: CHE) receives 386-share stock award - Stock Titan
CHEMED (NYSE: CHE) director Ron DeLyons granted 386 shares of stock - Stock Titan
Chemed Corporation Stockholders Elect Directors, Ratify Accountants, and Declare Quarterly Dividend - Quiver Quantitative
Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend - GlobeNewswire
220 consecutive dividends from the company behind VITAS and Roto-Rooter - Stock Titan
Chemed Corp (CHE) Stock Analysis: Evaluating the Healthcare Giant’s Growth Potential with a 2.75% Upside - DirectorsTalk Interviews
Chemed Conference Webcast Puts Dual Businesses And Valuation In Focus - Yahoo Finance
Chemed Corp stock (US1638321034): hospice and plumbing specialist draws investor focus after latest - AD HOC NEWS
TradingKey - TradingKey
Chemed Corp stock (US1638321034): Presentation at RBC Healthcare Conference - AD HOC NEWS
Chemed Corporation to Present at the 2026 RBC Global Healthcare Conference - Caledonian Record
Chemed Corp (CHE) Stock Analysis: Navigating the Healthcare Sector with a 5.24% Potential Upside - DirectorsTalk Interviews
C WorldWide Group Holding A S Invests $2.19 Million in Chemed Corporation $CHE - MarketBeat
How Chemed Corp (CHE) Affects Rotational Strategy Timing - Stock Traders Daily
CHE SEC FilingsChemed Corp 10-K, 10-Q, 8-K Forms - Stock Titan
[144] CHEMED CORP SEC Filing - Stock Titan
Chemed director Patrick P. Grace sells $25,546 in stock By Investing.com - Investing.com Australia
Chemed director Patrick P. Grace sells $25,546 in stock - Investing.com
Finanzdaten der Chemed Corp-Aktie (CHE)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.25%
2.98%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):